CytomX Therapeutics Inc
CTMX
$2.40-4.38%
End of day · as of Oct 22, 2026, 8:00 AM ET
Mkt cap
$653.11M
EV/Sales
8.40
P/E ratio
N/A
FY2025 Revenue
$76.20M
EPS (FY2025)
N/A
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-22.79%
Beta
2.09
Div yield
N/A
Sector
Healthcare
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Latest reported CTMX revenue for 2025-12-31 was $76.2M. Net income was -$17.4M. Revenue was down 44.8% from 2024-12-31 to 2025-12-31. CTMX currently screens at market cap $653.1M.
Use this CTMX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CTMX income, balance, and cash tables.
CytomX Therapeutics Inc (CTMX) is a biotechnology company in the Healthcare sector.
Latest cached CytomX Therapeutics Inc (CTMX) revenue for Dec 31, 2025 was $76.2M. Net income was -$17.4M. Statements: https://lician.com/financials/ctmx
CytomX Therapeutics Inc (CTMX) market capitalization is $653.1M on the latest cached snapshot.
CytomX Therapeutics Inc (CTMX) cached previous close $2.51; day range $2.39 – $2.61; volume 3,107,026. Session quote: https://lician.com/quote/ctmx
CytomX Therapeutics Inc (CTMX) latest cached earnings event is "CTMX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CTMX filing is 8-K · Jul 27, 2026. Filings: https://lician.com/sec/ctmx